Related Experiment Video
Updated: Jun 28, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production
Dahai Zheng1, Gang Chen, Beichu Guo
1Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Da Tun Road, Chaoyang District, Beijing 100101, China.
Abstract:
Infections by coronaviruses such as severe acute respiratory syndrome (SARS) coronavirus (SCoV) and mouse hepatitis virus A59 (MHV-A59) result in very little type I interferon (IFN) production by host cells, which is potentially responsible for the rapid viral growth and severe immunopathology associated with SARS. However, the molecular mechanisms for the low IFN production in cells infected with coronaviruses remain unclear. Here, we provide evidence that Papain-like protease domain 2 (PLP2), a catalytic domain of the nonstructural protein 3 (nsp3) of MHV-A59, can bind to IRF3, cause its deubiquitination and prevent its nuclear translocation. As a consequence, co-expression of PLP2 strongly inhibits CARDIF-, TBK1- and IRF3-mediated IFNbeta reporter activities. In addition, we show that wild-type PLP2 but not the mutant PLP2 lacking the deubiquitinase (DUB) activity can reduce IFN induction and promote viral growth in cells infected with VSV. Thus, our study uncovered a viral DUB which coronaviruses may use to escape from the host innate antiviral responses.
Insights
Coronaviruses evade host immunity by suppressing type I interferon production. This study identifies a viral protease, Papain-like protease domain 2 (PLP2), that inhibits interferon signaling by deubiquitinating IRF3.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Coronaviruses, including SARS-CoV, cause limited type I interferon (IFN) production, linked to severe disease.
- The precise molecular mechanisms behind this suppressed IFN response in coronavirus infections are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which coronaviruses inhibit host type I interferon production.
- To identify specific viral factors involved in evading innate antiviral responses.
Main Methods:
- Investigated the interaction between the coronavirus nonstructural protein 3 (nsp3) Papain-like protease domain 2 (PLP2) and IRF3.
- Assessed the effect of PLP2 on IRF3 ubiquitination and nuclear translocation using co-expression systems.
- Measured IFN-beta reporter gene activity upon co-expression of PLP2 and components of the IFN signaling pathway (CARDIF, TBK1, IRF3).
- Evaluated the impact of wild-type and catalytically inactive PLP2 on viral replication (VSV) and IFN induction in infected cells.
Main Results:
- Papain-like protease domain 2 (PLP2) of MHV-A59 binds to IRF3, promoting its deubiquitination.
- PLP2 inhibits the nuclear translocation of IRF3, a key transcription factor for IFN production.
- Co-expression of PLP2 significantly suppresses IFN-beta reporter activity mediated by CARDIF, TBK1, and IRF3.
- Wild-type PLP2, but not a mutant lacking deubiquitinase (DUB) activity, reduces IFN induction and enhances viral growth in VSV-infected cells.
Conclusions:
- Uncovered a viral deubiquitinase (DUB) activity within the coronavirus PLP2 domain.
- Coronaviruses likely utilize this PLP2 DUB to interfere with IRF3 activation and evade host innate antiviral immunity.
- This finding provides a molecular explanation for the impaired IFN response observed in coronavirus infections.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

